Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
31 Jul 2012  |  North America  |  Customer Research
Understanding the Peripheral Intervention Toolkit
An Analysis of Trends, Strategies, and Opportunities in the U.S. Peripheral Intervention Market
In February 2010, Frost & Sullivan surveyed 157 vascular surgeons, interventional cardiologists, and interventional radiologists on a broad range of issues relating to peripheral intervention procedures. This study is based on their responses to an extensive online questionnaire. The study addresses balloons and stents, atherectomy devices, thrombe...
$10,000.00
Special Price $7,500.00 save 25 %
-
24 May 2012  |  North America  |  Customer Research
Purchasing Trends in the Research Antibodies Market
Evaluating Budgets, Suppliers, and Unmet Needs
This study is based on input from 1,155 laboratory personnel who either participate in their laboratory's purchase of antibodies or are users of antibodies. Most survey participants are located in the United States, although participation was open to researchers globally. The objectives of this research are to identify points such as: types of rese...
$10,000.00
Special Price $7,500.00 save 25 %
-
08 May 2012  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends
A Survey of Laboratory Managers, Directors, Technicians, and Scientists
This study is based on a survey of 151 laboratory professionals working in a variety of laboratory types. They reveal their laboratories' current (2011) budgets and anticipated budget trends (for 2012) in seven product categories, and the top brands in each of these categories. The product categories and the brand with the highest unaided brand rec...
$10,000.00
Special Price $7,500.00 save 25 %
-
26 Mar 2012  |  North America  |  Customer Research
Investment Confidence Among Laboratory Decision Makers
In What Laboratory Products do Decision Makers Expect to Invest?
The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only slightly positive. In particular, laboratory decision makers generally expect their funding conditions to either remain the same or minimally impr...
$10,000.00
Special Price $7,500.00 save 25 %
-
20 Dec 2011  |  North America  |  Customer Research
Frost & Sullivan 2011 Survey of Sequencing Technologies: Instrument Adoption on the Rise as Affordable Systems Enter the Market
Frost & Sullivan 2011 Survey of Sequencing Technologies
The editors of Lab Manager Magazine and Frost & Sullivan recently conducted a survey to better understand the sequencing end-user base. A total of 79 Lab Manager Magazine readers qualified for the survey as current or future users of sequencing technology, representing research and clinical laboratories, core facilities, sequencing services provide...
$10,000.00
Special Price $7,500.00 save 25 %
-
12 Dec 2011  |  North America  |  Customer Research
Social Media Use Among the U.S. Healthcare Provider Institutions
Opportunities and Concerns for Social Media in Healthcare
Professional usage of social media (both individual and within institutional frames) is high within healthcare providers institutions. However, only a minority of provider institutions have a dedicated budget for social media. The majority of employees have access to social media in their workplace, but the majority of provider institutions using s...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Dec 2011  |  North America  |  Customer Research
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market
Insights into the Potential Reactions of Key Customers and Influence on Market Uptake
The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts and expectations of specialty physicians who would be expected to be among the first customers of biosimilar...
$10,000.00
Special Price $7,500.00 save 25 %
-
08 Dec 2011  |  North America  |  Customer Research
2011 Radiotherapy Today and Tomorrow
Future Opportunities and Weakness of the Radiotherapy Market
This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...
$10,000.00
Special Price $7,500.00 save 25 %
-
16 Sep 2011  |  North America  |  Customer Research
End-user Trends in the U.S. Next-Generation Sequencing Market
Preferences in Technologies, Applications, and Brands
In 2010, Frost & Sullivan launched an end-user survey to examine the use of genomics technologies, including next-generation sequencing, by researchers in academic and government laboratories, at pharmaceutical and biotechnology companies, and in hospital and clinical laboratories. This analysis is based on results from researchers from the various...
$10,000.00
Special Price $7,500.00 save 25 %
-
19 Aug 2011  |  North America  |  Customer Research
2011 U.S. Diabetes Injection Pens' Features
U.S. Diabetes Injection Pens' Features
A majority of type 2 diabetics currently use Lantus SoloSTAR Pen. Most of them use prefilled injection pens that are entirely disposable. These pens are more convenient to use for most patients with busy lifestyles, as they come pre-filled with insulin/medication. Easy push-button injection, transparent cartridge, and a window showing injection is ...
$10,000.00
Special Price $7,500.00 save 25 %